In a study on a murine CKD model, oral activated charcoal, which absorbs urea and urea-derived ammonia, reduced plasma endotoxin levels and other systemic inflammation mediators, including IL-6, TNF-α, and malondialdehyde, restoring the epithelial tight junction proteins [97]. Here, TNF is linked to chronic kidney disease.